| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AR086092 | In vivo imaging platform for DM1 drug discovery | 000 | 1 | NIH | 12/2/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $313,148 ) |
| | 2025 | 2025 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AR086092 | In vivo imaging platform for DM1 drug discovery | 000 | 1 | NIH | 7/29/2025 | $313,148 |
| | 2025 | 2024 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AI186768 | Targeted RNA degradation assay for new antiviral drug discovery | 000 | 1 | NIH | 9/18/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $692,116 ) |
| | 2024 | 2024 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AI186768 | Targeted RNA degradation assay for new antiviral drug discovery | 000 | 1 | NIH | 7/29/2024 | $300,000 |
| | 2024 | 2024 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AG085837 | Cell-based RNA degradation assay for C9ALS/FTD drug discovery | 000 | 1 | NIH | 11/17/2023 | $392,116 |
| | 2024 | 2023 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R44NS130946 | Fluorescent IRE sensor for synucleinopathy drug discovery | 001 | 2 | NIH | 4/19/2024 | $0 |
| | 2024 | 2022 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R44NS130946 | Fluorescent IRE sensor for synucleinopathy drug discovery | 000 | 1 | NIH | 4/18/2024 | $0 |
| | 2024 | 2020 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43CA250841 | Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery | 000 | 1 | NIH | 12/21/2023 | $0 |
| | 2024 | 2020 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AI150006 | Cell-based assay directly monitoring viral polymerase activity for drug discovery. | 000 | 1 | NIH | 10/23/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $874,414 ) |
| | 2023 | 2023 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R44NS130946 | Fluorescent IRE sensor for synucleinopathy drug discovery | 001 | 2 | NIH | 8/9/2023 | $874,414 |
| | 2023 | 2022 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R44NS130946 | Fluorescent IRE sensor for synucleinopathy drug discovery | 000 | 1 | NIH | 2/8/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $845,353 ) |
| | 2022 | 2022 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44NS130946 | Fluorescent IRE sensor for synucleinopathy drug discovery | 000 | 1 | NIH | 9/21/2022 | $853,817 |
| | 2022 | 2020 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R44CA206804 | Splice sensors for cancer drug discovery | 000 | 4 | NIH | 8/19/2022 | $0 |
| | 2022 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43CA250841 | Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery | 000 | 1 | NIH | 11/1/2021 | $0 |
| | 2022 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43CA250841 | Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery | 001 | 1 | NIH | 4/6/2022 | $0 |
| | 2022 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI150006 | Cell-based assay directly monitoring viral polymerase activity for drug discovery. | 000 | 1 | NIH | 11/12/2021 | $0 |
| | 2022 | 2018 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43GM130258 | Assay Classifier Engine (ACE) for enhancing splice sensor assay performance | 000 | 1 | NIH | 6/29/2022 | -$8,464 |
| | 2022 | 2018 | LUCERNA INC | 760 PARKSIDE AVE | BROOKLYN | NY | 11226-1787 | KINGS | USA | R43AI140867 | Cell-based viral helicase assay for dengue drug discovery | 000 | 1 | NIH | 1/28/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI150006 | Cell-based assay directly monitoring viral polymerase activity for drug discovery. | 000 | 1 | NIH | 12/15/2020 | $0 |
| | 2021 | 2019 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AT009951 | New high-throughput screening technologies to improve cannabinoid production in yeast. | 000 | 1 | NIH | 5/28/2021 | $0 |
| | 2021 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43GM130258 | Assay Classifier Engine (ACE) for enhancing splice sensor assay performance | 000 | 1 | NIH | 5/2/2021 | $0 |
| | 2021 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AG058338 | Fluorescent IRE sensor for PD drug discovery | 000 | 1 | NIH | 4/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $981,315 ) |
| | 2020 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44CA206804 | Splice sensors for cancer drug discovery | 001 | 4 | NIH | 3/20/2020 | $533,292 |
| | 2020 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI150006 | Cell-based assay directly monitoring viral polymerase activity for drug discovery. | 000 | 1 | NIH | 12/5/2019 | $224,323 |
| | 2020 | 2020 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43CA250841 | Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery | 000 | 1 | NIH | 3/30/2020 | $223,700 |
| | 2020 | 2019 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44CA206804 | Splice sensors for cancer drug discovery | 000 | 3 | NIH | 1/17/2020 | $0 |
| | 2020 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AG058338 | Fluorescent IRE sensor for PD drug discovery | 000 | 1 | NIH | 7/27/2020 | $0 |
| | 2020 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43GM130258 | Assay Classifier Engine (ACE) for enhancing splice sensor assay performance | 000 | 1 | NIH | 8/25/2020 | $0 |
| | 2020 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI140867 | Cell-based viral helicase assay for dengue drug discovery | 000 | 1 | NIH | 8/7/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $579,843 ) |
| | 2019 | 2019 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AT009951 | New high-throughput screening technologies to improve cannabinoid production in yeast. | 000 | 1 | NIH | 11/19/2018 | $224,928 |
| | 2019 | 2019 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44CA206804 | Splice sensors for cancer drug discovery | 000 | 3 | NIH | 6/17/2019 | $354,915 |
| | 2019 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AG058338 | Fluorescent IRE sensor for PD drug discovery | 000 | 1 | NIH | 1/18/2019 | $0 |
| | 2019 | 2017 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43GM122166 | Fluorescent reporters for real-time single-cell Pol III transcription measurement | 000 | 1 | NIH | 6/5/2019 | $0 |
| | 2019 | 2016 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44MH096366 | New toolkit to visualize RNAs in living cells | 000 | 4 | NIH | 11/29/2018 | $0 |
| | 2019 | 2016 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43CA206804 | Splice sensors for cancer drug discovery | 000 | 1 | NIH | 12/20/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,049,882 ) (Continued on the next page) |
| | 2018 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43GM130258 | Assay Classifier Engine (ACE) for enhancing splice sensor assay performance | 000 | 1 | NIH | 7/27/2018 | $224,925 |
| | 2018 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI140867 | Cell-based viral helicase assay for dengue drug discovery | 000 | 1 | NIH | 5/10/2018 | $224,475 |
| | 2018 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AI140867 | Cell-based viral helicase assay for dengue drug discovery | 001 | 1 | NIH | 9/7/2018 | $0 |
| | 2018 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43AG058338 | Fluorescent IRE sensor for PD drug discovery | 000 | 1 | NIH | 6/30/2018 | $221,896 |
| | 2018 | 2018 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R44CA206804 | Splice sensors for cancer drug discovery | 000 | 2 | NIH | 3/19/2018 | $603,137 |
| | 2018 | 2017 | LUCERNA INC. | 760 PARKSIDE AVE STE 311 | BROOKLYN | NY | 11226-1784 | KINGS | USA | R43GM122166 | Fluorescent reporters for real-time single-cell Pol III transcription measurement | 000 | 1 | NIH | 2/14/2018 | $0 |
|
